MedPath

Effect of Intraoperative Remifentanil Infusion Rate on Postoperative Tolerance and Analgesic Consumption in Pediatric Laparoscopic Ureteroneocystostomy

Not Applicable
Conditions
Pediatrics
Interventions
Registration Number
NCT01147757
Lead Sponsor
Yonsei University
Brief Summary

Effect of intraoperative remifentanil infusion rate on postoperative tolerance and analgesic consumption in pediatric laparoscopic ureteroneocystostomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Pediatric patients (ASA physical status I and II) aged between 1-5 yrs and scheduled elective laparoscopic ureteroneocystostomy
Exclusion Criteria
  • cardiovascular, renal, liver disease or growth retardation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
salineremifentanilGroup S (n = 15): saline
remifentanil 0.3 mcg/kg/minremifentanilGroup 0.3 (n = 15): remifentanil 0.3 mcg/kg/min
remifentanil 0.6 mcg/kg/minremifentanilGroup 0.6 (n = 15): remifentanil 0.6 mcg/kg/min
remifentanil 0.9 mcg/kg/minremifentanilGroup 0.9 (n = 15): remifentanil 0.9 mcg/kg/min
Primary Outcome Measures
NameTimeMethod
fentanyl consumption for IV-PCA24 h and 48 h after surgery
Postoperative pain scoreduring 48 h after surgery
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath